CO5080748A1 - NUEVOS 2,3,3a,4,9,9a,-HEXADIDRO-8-HIDROXI-1H-BENZO[f]INDOLES PROCEDIMIENTO PARA SU PREPARACION Y SU UTILIZACION COMO MEDICAMENTOS - Google Patents
NUEVOS 2,3,3a,4,9,9a,-HEXADIDRO-8-HIDROXI-1H-BENZO[f]INDOLES PROCEDIMIENTO PARA SU PREPARACION Y SU UTILIZACION COMO MEDICAMENTOSInfo
- Publication number
- CO5080748A1 CO5080748A1 CO99048374A CO99048374A CO5080748A1 CO 5080748 A1 CO5080748 A1 CO 5080748A1 CO 99048374 A CO99048374 A CO 99048374A CO 99048374 A CO99048374 A CO 99048374A CO 5080748 A1 CO5080748 A1 CO 5080748A1
- Authority
- CO
- Colombia
- Prior art keywords
- hydrogen
- methyl
- benzo
- procedure
- preparation
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 8
- 239000001257 hydrogen Substances 0.000 abstract 8
- 150000002431 hydrogen Chemical class 0.000 abstract 7
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 4
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- REVUJGBPDQRBRB-UHFFFAOYSA-N 2,3,3a,4,9,9a-hexahydro-1h-benzo[f]indole Chemical class C1C2=CC=CC=C2CC2C1CCN2 REVUJGBPDQRBRB-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229940054051 antipsychotic indole derivative Drugs 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Derivados de 2,3,3a,4,9,9a-hexahidro-1H-benzo[f]indol, procedimiento para su preparación así como su utilización como medicamentos. Los derivados de indol conformes al invento corresponden a la fórmula general I:<EMI FILE="99048374_1" ID="1" IMF=JPEG >en la que pueden significar:X un enlace simple, -O-, alquilo C1-C4, alcoxi C1-C3,-O-CH2 -CH2 -O- ó -O-CH2 -CH2 -NH-; R1 hidrógeno, metilo, etilo o fenilo;R2 hidrógeno o metilo,R3 hidrógeno, F, Cl, Br, hidroxi o metoxi;R4 hidrógeno, metilo o etilo;R5 hidrógeno, metilo o etilo;R6 hidrógeno, metilo o etilo;R7 Terc.-butilo, ciclohexilo,<EMI FILE="99048374_2" ID="2" IMF=JPEG >n un número entero de 0 ó 1;Y N ó CH;Z O, NH ó S;R8 hidrógeno, metilo, F, CL, Br o metoxi;R9 hidrógeno, metilo, F, Cl, Br o metoxi.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19834714A DE19834714A1 (de) | 1998-07-31 | 1998-07-31 | Neue 2,3,3a,4,9,9a-Hexahydro-8-hydroxy-1H-ben[f]indole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5080748A1 true CO5080748A1 (es) | 2001-09-25 |
Family
ID=7876092
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO99048374A CO5080748A1 (es) | 1998-07-31 | 1999-07-30 | NUEVOS 2,3,3a,4,9,9a,-HEXADIDRO-8-HIDROXI-1H-BENZO[f]INDOLES PROCEDIMIENTO PARA SU PREPARACION Y SU UTILIZACION COMO MEDICAMENTOS |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6051583A (es) |
| EP (1) | EP1100780B1 (es) |
| JP (1) | JP2002522418A (es) |
| KR (1) | KR20010072142A (es) |
| CN (1) | CN1147470C (es) |
| AT (1) | ATE360611T1 (es) |
| AU (1) | AU763834B2 (es) |
| BG (1) | BG105178A (es) |
| BR (1) | BR9912605A (es) |
| CA (1) | CA2336783C (es) |
| CO (1) | CO5080748A1 (es) |
| DE (2) | DE19834714A1 (es) |
| EA (1) | EA003370B1 (es) |
| EE (1) | EE200100062A (es) |
| ES (1) | ES2285851T3 (es) |
| HK (1) | HK1038017A1 (es) |
| HU (1) | HUP0103518A3 (es) |
| ID (1) | ID28292A (es) |
| IL (1) | IL140863A0 (es) |
| MY (1) | MY133085A (es) |
| NO (1) | NO20010513D0 (es) |
| NZ (1) | NZ510246A (es) |
| PL (1) | PL345808A1 (es) |
| SK (1) | SK1502001A3 (es) |
| TR (1) | TR200100316T2 (es) |
| TW (1) | TW464643B (es) |
| UA (1) | UA68388C2 (es) |
| WO (1) | WO2000007986A1 (es) |
| YU (1) | YU5501A (es) |
| ZA (1) | ZA200007770B (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0002666D0 (en) | 2000-02-04 | 2000-03-29 | Univ London | Blockade of voltage dependent sodium channels |
| DK1458386T3 (da) * | 2001-12-27 | 2007-08-13 | Ortho Mcneil Pharm Inc | Aroylpyrrolheteroaryl- og methanolforbindelser til behandling af en lidelse i centralnervesystemet |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2057912C (en) * | 1989-07-13 | 1996-10-29 | Chiu-Hong Lin | (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
| EP0586553A1 (en) * | 1991-05-20 | 1994-03-16 | The Upjohn Company | Carboxamido-(3,2n)-carbocyclic-2-aminotetralin derivatives |
| GB9612153D0 (en) * | 1996-06-11 | 1996-08-14 | Smithkline Beecham Plc | Compounds |
-
1998
- 1998-07-31 DE DE19834714A patent/DE19834714A1/de not_active Ceased
-
1999
- 1999-07-22 NZ NZ510246A patent/NZ510246A/en unknown
- 1999-07-22 SK SK150-2001A patent/SK1502001A3/sk unknown
- 1999-07-22 WO PCT/EP1999/005222 patent/WO2000007986A1/de active IP Right Grant
- 1999-07-22 DE DE59914314T patent/DE59914314D1/de not_active Expired - Fee Related
- 1999-07-22 EP EP99936584A patent/EP1100780B1/de not_active Expired - Lifetime
- 1999-07-22 UA UA2001021382A patent/UA68388C2/uk unknown
- 1999-07-22 ID IDW20010244A patent/ID28292A/id unknown
- 1999-07-22 CA CA002336783A patent/CA2336783C/en not_active Expired - Fee Related
- 1999-07-22 PL PL99345808A patent/PL345808A1/xx not_active Application Discontinuation
- 1999-07-22 IL IL14086399A patent/IL140863A0/xx unknown
- 1999-07-22 CN CNB998089702A patent/CN1147470C/zh not_active Expired - Fee Related
- 1999-07-22 AU AU51626/99A patent/AU763834B2/en not_active Ceased
- 1999-07-22 EE EEP200100062A patent/EE200100062A/xx unknown
- 1999-07-22 KR KR1020017001334A patent/KR20010072142A/ko not_active Application Discontinuation
- 1999-07-22 TR TR2001/00316T patent/TR200100316T2/xx unknown
- 1999-07-22 ES ES99936584T patent/ES2285851T3/es not_active Expired - Lifetime
- 1999-07-22 HU HU0103518A patent/HUP0103518A3/hu unknown
- 1999-07-22 EA EA200100107A patent/EA003370B1/ru not_active IP Right Cessation
- 1999-07-22 AT AT99936584T patent/ATE360611T1/de not_active IP Right Cessation
- 1999-07-22 BR BR9912605-2A patent/BR9912605A/pt not_active IP Right Cessation
- 1999-07-22 YU YU5501A patent/YU5501A/sh unknown
- 1999-07-22 JP JP2000563620A patent/JP2002522418A/ja active Pending
- 1999-07-29 MY MYPI99003229A patent/MY133085A/en unknown
- 1999-07-29 TW TW088112896A patent/TW464643B/zh not_active IP Right Cessation
- 1999-07-30 CO CO99048374A patent/CO5080748A1/es unknown
- 1999-07-30 US US09/365,064 patent/US6051583A/en not_active Expired - Lifetime
-
2000
- 2000-12-21 ZA ZA200007770A patent/ZA200007770B/en unknown
-
2001
- 2001-01-24 BG BG105178A patent/BG105178A/xx active Pending
- 2001-01-30 NO NO20010513A patent/NO20010513D0/no not_active Application Discontinuation
- 2001-12-19 HK HK01108875A patent/HK1038017A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5550421A2 (es) | Derivados de indol utiles para el tratamiento de enfermeda- des | |
| YU83602A (sh) | Derivati fenilglicina | |
| HUP0302962A2 (hu) | Béta-karbolinszármazékok, ezeket a vegyületeket tartalmazó gyógyászati készítmények és a vegyületek alkalmazása | |
| AR006906A1 (es) | Derivados de indazol sustituidos, composiciones farmaceuticas que los contienen, uso de los mismos e intermediarios de sintesis | |
| CO5630036A2 (es) | Nuevos derivados indol con afinidad por el receptor 5-ht6 | |
| BR0316645A (pt) | Derivados de isoindol | |
| AR045768A1 (es) | Compuestos de cefem y sus sales farmaceuticamente aceptables | |
| MXPA05010174A (es) | Derivados de indol e indolina sustituidos. | |
| MY138826A (en) | 2,7-substituted indoles | |
| MY147504A (en) | Electrode for energy storage device and method for making same | |
| CO5150179A1 (es) | Derivados de n-etilpirimidin o (piridin)-2-(1,2-benzoisoxa- zol-3-il)-octahidro-2h-pirido[1,2-a]pirazina y sus composiciones farmaceuticas | |
| EP1659121A4 (en) | D RIV OF 1,3-DIHYDRO-2H-INDOL-2-ONE | |
| MY136938A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| CO5080748A1 (es) | NUEVOS 2,3,3a,4,9,9a,-HEXADIDRO-8-HIDROXI-1H-BENZO[f]INDOLES PROCEDIMIENTO PARA SU PREPARACION Y SU UTILIZACION COMO MEDICAMENTOS | |
| EA200600898A1 (ru) | Новый способ синтеза периндоприла и его фармацевтически приемлемых солей | |
| MY139159A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| CO5170535A1 (es) | Derivados de n-[2-(4-aminofenil)etil]2,3-dihidro-1,4- benzodioxin-2-metanamina, su preparacion y su aplciacion en terapeutica | |
| MXPA03003971A (es) | Derivados de indol como inhibidores de pde5. | |
| MY135359A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
| MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts | |
| CO5170443A1 (es) | Derivados de coclobuten-3,4-diona,su preparacion y su aplicacion terapeutica. | |
| ES2188515T3 (es) | Derivados de 22r-hidroxicolesta-8,14-dieno con actividad inhibidora de la meiosis. | |
| MY139348A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| MY136851A (en) | New process for the synthesis of (2s, 3as, 7as)-1-[(s)-alanyl]-octahydro-1h-indole-2-carboxylic acid compounds and application in the synthesis of perindopril | |
| MY136638A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts |